A woman in Pennsylvania has become the first person to ever receive a vaccine for early-stage breast cancer.
“It is a personal decision, and we really need to make sure more women survive breast cancer,” Maria Kitay, the patient who received the vaccine, shared.
Kitay received the vaccine at the UPMC Magee Women’s Hospital in Pittsburgh.
“We look forward to many more women signing up for this trial; this is a very innovative way to approach a breast cancer diagnosis, especially a pre-cancer diagnosis,” Dr. Olivera Finn, the immunologist who invented the vaccine said.
The vaccine, given in three doses, was “developed over decades of research” by the University of Pittsburgh and Dr. Finn, CBS News reported.
Earlier this week, American Faith reported that doctors Peter McCullough and Sherri Tenpenny criticized a study suggesting pregnant women receive the respiratory syncytial virus (RSV) vaccine.
The study warned that the infection may threaten unborn babies, as it “highlights the potential importance of even subtle events occurring in pregnant women (e.g., apparently inconsequential head colds) for the future development and well-being of the offspring.”
A maternal infection may “damage” the unborn baby through the “activation of maternal inflammation and immunity, transfer of soluble inflammatory mediators, and mobilization of cellular effectors or by impairing placental function and limiting the passage of nutrients and other factors essential for fetal growth,” the researchers wrote.
